ER
CRL icon

Enlightenment Research’s Charles River Laboratories CRL Stock Holding History

Enlightenment Research’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-700
Closed -$203K – 149
2021
Q1 		$203K Buy
+700
New +$195K 0.24% 128
2019
Q1 		– Sell
-200
Closed -$23K – 224
2018
Q4 		$23K Buy
+200
New +$25K 0.03% 423

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Enlightenment Research's CRL Position: Q2 2021 in Review

Enlightenment Research sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 700 shares — an estimated $203K sold.

Enlightenment Research first reported a position in CRL in Q4 2018 and held it in 2 quarters. The position peaked at $203K in Q1 2021. 638 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

  • Enlightenment Research reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
  • Enlightenment Research sold 700 Charles River Laboratories shares in Q2 2021, an estimated $203K.
  • Enlightenment Research first reported a position in Charles River Laboratories in Q4 2018 and held it in 2 quarters.
  • Enlightenment Research's Charles River Laboratories position peaked at $203K in Q1 2021.
  • 638 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Enlightenment Research's 13F filing for Q2 2021, filed 16 Aug 2021.